Dr. Bradley McConnell was recently promoted to full Professor of Pharmacology at the University of Houston, College of Pharmacy, Department of Pharmacological and Pharmaceutical Sciences.  Dr. McConnell has been a faculty member at the University of Houston since 2008 and leads a successful research program where he and his research team are interested in defining β-adrenergic receptor (β-AR) mediated “biased” signaling, characterizing A-kinase Anchoring Protein (AKAP) “signalosomes” mediated signaling, and reprogramming progenitor cells to form mature cardiac conduction cells for heart repair. His research has been supported by the National Institutes of Health, the American Heart Association, and the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation. Dr. McConnell is a long-standing ASPET member and currently is serving as the Programming Chair of ASPET’s Division of Cardiovascular Pharmacology (CVD). Dr. McConnell is also a Fellow of the American Heart Association (FAHA) and Fellow of the American Physiological Society’s Cardiovascular Section (FCVS).